Meifang Huang

Hubei Clinical Center And Key Laboratory For Intestinal And Colorectal Diseases
Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The canonical Hippo pathway components modulate the differentiation of lamina propria regulatory T cells and T helper 17-like regulatory T cells in mouse colitis.

The canonical Hippo pathway components modulate the differentiation of lamina propria regulatory T cells and T helper 17-like regulatory T cells in mouse colitis.

Journal: International immunology

Published: August 07, 2023

Sirtuin2 suppresses the polarization of regulatory T cells toward T helper 17 cells through repressing the expression of signal transducer and activator of transcription 3 in a mouse colitis model.

Sirtuin2 suppresses the polarization of regulatory T cells toward T helper 17 cells through repressing the expression of signal transducer and activator of transcription 3 in a mouse colitis model.

Journal: Immunity, inflammation and disease

Published: July 28, 2023

Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.

Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.

Journal: Virchows Archiv : an international journal of pathology

Published: April 30, 2022

A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China.

A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China.

Journal: Journal of inflammation research

Published: December 09, 2021

Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.

Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.

Journal: BMC gastroenterology

Published: February 19, 2019

Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.

Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.

Journal: The American journal of gastroenterology

Published: February 12, 2019

JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.

JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.

Journal: Frontiers in immunology

Published: February 23, 2017

Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.

Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: December 15, 2016

Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease.

Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease.

Journal: Medicine

Published: August 15, 2014

Coagulation state in patients with Crohn's disease: the effect of infliximab therapy.

Coagulation state in patients with Crohn's disease: the effect of infliximab therapy.

Journal: European journal of gastroenterology & hepatology

Published: July 30, 2014

Risk factors for initial surgery in patients with Crohn's disease in Central China.

Risk factors for initial surgery in patients with Crohn's disease in Central China.

Journal: Surgery today

Published: May 29, 2014

Elevated risk of opportunistic viral infection in patients with Crohn's disease during biological therapies: a meta analysis of randomized controlled trials.

Elevated risk of opportunistic viral infection in patients with Crohn's disease during biological therapies: a meta analysis of randomized controlled trials.

Journal: European journal of clinical pharmacology

Published: March 20, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026